05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
The recent Italian Tax Decree 2020 (Decree-Law no. 124 of 26 October, 2019, converted into Law no. 1...
Read More >
The National Labor Relations Board just relaxed its test for determining the legality of an employer...
Read More >
As of June 17, 2019, travelers from the United States may enter Brazil for periods up to 90 days wit...
Read More >
Welcome to your weekly update from the Allen & Overy Pensions team, bringing you up to spee?d on the...
Read More >
After much anticipation, on September 24, 2019 the U.S. Department of Labor (DOL) announced a final ...
Read More >
The question of categorizing high-tech companies as software industry companies arises in many due d...
Read More >